This article is an excerpt from a blog post originally published on biodesignalumni.com
The Stanford Biodesign Alumni Association recently dined with Angela Macfarlane, CEO of the ophthalmology incubator ForSight Labs at the October Tableside Chat.
As the dust settles after another earnings season, it’s time to look back at what we now know about the state of the industry. Stocks in the sector have been enjoying a run that started in November 2012 on hopes for improving utilization trends and earnings in 2013.